biology-technology-1/neuralstem-receives-fda-approval-to-commence-first-als-stem-cell-trial-14171-3/;msg90356

Breaking Biology Technology:Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2 Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3 Martek Signs Sole-Source Supply Agreement with Fonterra 2 Martek Signs Sole-Source Supply Agreement with Fonterra 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3

[0] Lotus Pharmaceuticals, Inc. Appoints OTC Division Head [0] Martek Signs Sole-Source Supply Agreement with Fonterra [0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES [0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years

Breaking Medicine Technology:Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5 Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2 Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3 Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4 Hand Surgeons Take Ethics into Their Own Hands 2 Hand Surgeons Take Ethics into Their Own Hands 3 Hand Surgeons Take Ethics into Their Own Hands 4 Cornell makes cancer vaccine for clinical use 54990 1 Cornell makes cancer vaccine for clinical use 54990 2 Cornell makes cancer vaccine for clinical use 54990 3 CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco 54987 1 CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco 54987 2 Increase in visceral fat during menopause linked with testosterone 9643 1 Increase in visceral fat during menopause linked with testosterone 9643 2

[0] Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy [0] Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential [0] Hand Surgeons Take Ethics into Their Own Hands